Clinical trial
Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones
NCT00151567 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones
- Lead sponsor
- Rennes University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- December 31, 2006
- Enrollment
- 129 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.